BioSpace News Archive

Pharm Country

Tonix Pharmaceuticals Announces Issuance of U.S. Patent for TNX-801 Smallpox and Monkeypox Vaccine and Recombinant Pox Virus (RPV) Platform Technology

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced that the United States Patent and Trademark Office issued U.S. Patent No. 11,345,896 to the Company on May 31, 2022.

June 1, 2022
·
10 min read
Kamada to Host a Virtual Analysts and Investors Meeting to Review its Growth Catalysts

Kamada Ltd. announced that it will host a virtual analysts and investors meeting on Tuesday, June 7, 2022, at 12:00 PM Eastern Time to review its growth catalysts.

June 1, 2022
·
3 min read
Policy

Apellis Announces Submission of New Drug Application to the FDA for Pegcetacoplan for Geographic Atrophy

Apellis Pharmaceuticals, Inc. announced that the company has submitted a New Drug Application to the United States Food and Drug Administration for intravitreal pegcetacoplan, an investigational, targeted C3 therapy, for the treatment of geographic atrophy secondary to age-related macular degeneration.

June 1, 2022
·
6 min read
Biotech Bay

IGM Biosciences to Present at the 2022 Jefferies Healthcare Conference

IGM Biosciences, Inc. announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the 2022 Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 3:00 p.m. EST in New York.

June 1, 2022
·
1 min read
Pharm Country

Axsome Therapeutics Announces Late-Breaking Presentations of Positive Results of the EVOLVE Trial of AXS-05 in Major Depressive Disorder After Prior Treatment Failures at the American Society of Clinical Psychopharmacology 2022 Annual Meeting

Axsome Therapeutics, Inc. announced positive results from the long-term, open-label EVOLVE trial of AXS-05 in major depressive disorder.

June 1, 2022
·
9 min read
Genetown

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences - June 01, 2022

Apellis Pharmaceuticals, Inc., a global biopharmaceutical company and leader in complement, announced that the company will participate in the following investor conferences in June.

June 1, 2022
·
1 min read
Biotech Beach

Opiant Pharmaceuticals Initiates Rolling Submission of New Drug Application to U.S. Food and Drug Administration for OPNT003, Nasal Nalmefene, for the Treatment of Opioid Overdose

Opiant Pharmaceuticals, Inc. (Opiant) (NASDAQ: OPNT) today announced the filing of the first module of its New Drug Application (NDA) for OPNT003, nasal nalmefene, for the treatment of opioid overdose.

June 1, 2022
·
4 min read
Icosavax to Participate in the Jefferies Healthcare Conference

Icosavax, Inc. announced that the company will participate in the Jefferies Healthcare Conference taking place from June 8-10, 2022.

June 1, 2022
·
3 min read
Press Releases

Sana Biotechnology Announces Plan to Relocate Manufacturing to Bothell, Washington Along with Key Executive Hires in Manufacturing and Regulatory

Sana Biotechnology, Inc. announced that the company has entered into a lease agreement to develop an approximately 80,000 square foot manufacturing facility in Bothell, Washington.

June 1, 2022
·
5 min read
Biotech Bay

Akero Therapeutics to Present at the Jefferies Global Healthcare Conference

Akero Therapeutics, Inc. announced that management will present at the Jefferies Global Healthcare Conference on Thursday, June 9, 2022, at 4:00 p.m. E.T.

June 1, 2022
·
1 min read